These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 741207)

  • 1. Plasma C-peptide in uraemic patients.
    Regeur L; Faber OK; Binder C
    Scand J Clin Lab Invest; 1978 Dec; 38(8):771-5. PubMed ID: 741207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failure.
    Barreca T; Robaudo C; Cataldi A; Garibaldi A; Cianciosi P; Russo R; Rolandi E; Franceschini R
    Biomed Pharmacother; 1995; 49(6):283-7. PubMed ID: 7579009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin release in response to glucose is impaired in chronic renal failure.
    Franceschini R; Robaudo C; Corsini G; Cataldi A; Bruno E; Russo R; Rolandi E; Barreca T
    Biomed Pharmacother; 1998; 52(5):208-13. PubMed ID: 9755817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure].
    Jovanović D; Djukanović Lj; Veljović R; Manojlović D
    Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C-peptide in renal failure patients following stimulation of pancreatic secretion.
    Ramirez G; O'Neill WM; Bloomer HA; Jubiz W
    Clin Nephrol; 1979 Jun; 11(6):297-301. PubMed ID: 477046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglucagonemia of renal failure.
    Bilbrey GL; Faloona GR; White MG; Knochel JP
    J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
    Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
    Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ; Medbak S; Drury PL; Cudworth AG
    Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the elevated extracellular concentration of cyclic AMP in uremic man.
    Hamet P; Stouder DA; Ginn HE; Hardman JG; Liddle GW
    J Clin Invest; 1975 Aug; 56(2):339-45. PubMed ID: 168232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of plasma amylin in advanced renal failure.
    Watschinger B; Hartter E; Traindl O; Pohanka E; Pidlich J; Kovarik J
    Clin Nephrol; 1992 Mar; 37(3):131-4. PubMed ID: 1563116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma homocysteine concentration in patients with chronic renal failure.
    Chauveau P; Chadefaux B; Coudé M; Aupetit J; Hannedouche T; Kamoun P; Jungers P
    Miner Electrolyte Metab; 1992; 18(2-5):196-8. PubMed ID: 1465057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose metabolism in chronic renal failure: adaptive responses to continuous glucose infusion.
    Ricanati ES; Tserng KY; Kalhan SC
    Kidney Int Suppl; 1983 Dec; 16():S121-7. PubMed ID: 6376912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.